233 related articles for article (PubMed ID: 23927577)
21. Molecular Mechanism of RNA Polymerase II Transcriptional Mutagenesis by the Epimerizable DNA Lesion, Fapy·dG.
Gao S; Hou P; Oh J; Wang D; Greenberg MM
J Am Chem Soc; 2024 Mar; 146(9):6274-6282. PubMed ID: 38393762
[TBL] [Abstract][Full Text] [Related]
22. Understanding and improving platinum anticancer drugs--phenanthriplatin.
Johnstone TC; Park GY; Lippard SJ
Anticancer Res; 2014 Jan; 34(1):471-6. PubMed ID: 24403503
[TBL] [Abstract][Full Text] [Related]
23. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
Lovejoy KS; Todd RC; Zhang S; McCormick MS; D'Aquino JA; Reardon JT; Sancar A; Giacomini KM; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8902-7. PubMed ID: 18579768
[TBL] [Abstract][Full Text] [Related]
24. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
[TBL] [Abstract][Full Text] [Related]
25. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
Vaisman A; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2000 Apr; 39(16):4575-80. PubMed ID: 10769112
[TBL] [Abstract][Full Text] [Related]
26. Is the cytotoxic activity of phenanthriplatin dependent on the specific size of the phenanthridine ligand π system?
Scoditti S; Dabbish E; Sicilia E
J Inorg Biochem; 2021 Jun; 219():111447. PubMed ID: 33798829
[TBL] [Abstract][Full Text] [Related]
27. DNA adducts from a tumorigenic metabolite of benzo[a]pyrene block human RNA polymerase II elongation in a sequence- and stereochemistry-dependent manner.
Perlow RA; Kolbanovskii A; Hingerty BE; Geacintov NE; Broyde S; Scicchitano DA
J Mol Biol; 2002 Aug; 321(1):29-47. PubMed ID: 12139931
[TBL] [Abstract][Full Text] [Related]
28. Extending the understanding of mutagenicity: structural insights into primer-extension past a benzo[a]pyrene diol epoxide-DNA adduct.
Perlow RA; Broyde S
J Mol Biol; 2003 Apr; 327(4):797-818. PubMed ID: 12654264
[TBL] [Abstract][Full Text] [Related]
29. Using Theory To Reinterpret the Kinetics of Monofunctional Platinum Anticancer Drugs: Stacking Matters.
Veclani D; Melchior A; Tolazzi M; Cerón-Carrasco JP
J Am Chem Soc; 2018 Oct; 140(43):14024-14027. PubMed ID: 30185041
[TBL] [Abstract][Full Text] [Related]
30. Structural basis of transcriptional stalling and bypass of abasic DNA lesion by RNA polymerase II.
Wang W; Walmacq C; Chong J; Kashlev M; Wang D
Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2538-E2545. PubMed ID: 29487211
[TBL] [Abstract][Full Text] [Related]
31. Conformation and recognition of DNA damaged by antitumor cis-dichlorido platinum(II) complex of CDK inhibitor bohemine.
Novakova O; Liskova B; Vystrcilova J; Suchankova T; Vrana O; Starha P; Travnicek Z; Brabec V
Eur J Med Chem; 2014 May; 78():54-64. PubMed ID: 24675180
[TBL] [Abstract][Full Text] [Related]
32. Two new monofunctional platinum(II) dithiocarbamate complexes:
Imran M; Rehman ZU; Hogarth G; Tocher DA; Chaudhry GE; Butler IS; Bélanger-Gariepy F; Kondratyuk T
Dalton Trans; 2020 Nov; 49(43):15385-15396. PubMed ID: 33140800
[TBL] [Abstract][Full Text] [Related]
33. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
Chaney SG; Campbell SL; Bassett E; Wu Y
Crit Rev Oncol Hematol; 2005 Jan; 53(1):3-11. PubMed ID: 15607931
[TBL] [Abstract][Full Text] [Related]
34. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
Bassett E; Vaisman A; Tropea KA; McCall CM; Masutani C; Hanaoka F; Chaney SG
DNA Repair (Amst); 2002 Dec; 1(12):1003-16. PubMed ID: 12531010
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of RNA polymerase II stalling by DNA alkylation.
Malvezzi S; Farnung L; Aloisi CMN; Angelov T; Cramer P; Sturla SJ
Proc Natl Acad Sci U S A; 2017 Nov; 114(46):12172-12177. PubMed ID: 29087308
[TBL] [Abstract][Full Text] [Related]
36. Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.
Zhu G; Chang P; Lippard SJ
Biochemistry; 2010 Jul; 49(29):6177-83. PubMed ID: 20550106
[TBL] [Abstract][Full Text] [Related]
37. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
[TBL] [Abstract][Full Text] [Related]
38. Miscoding properties of 6alpha- and 6beta-diastereoisomers of the N(2)-(estradiol-6-yl)-2'-deoxyguanosine DNA adduct by Y-family human DNA polymerases.
Poon K; Itoh S; Suzuki N; Laxmi YR; Yoshizawa I; Shibutani S
Biochemistry; 2008 Jun; 47(25):6695-701. PubMed ID: 18512958
[TBL] [Abstract][Full Text] [Related]
39. Translesion synthesis of acetylaminofluorene-dG adducts by DNA polymerase zeta is stimulated by yeast Rev1 protein.
Guo D; Xie Z; Shen H; Zhao B; Wang Z
Nucleic Acids Res; 2004; 32(3):1122-30. PubMed ID: 14960722
[TBL] [Abstract][Full Text] [Related]
40. Effects of monofunctional platinum agents on bacterial growth: a retrospective study.
Johnstone TC; Alexander SM; Lin W; Lippard SJ
J Am Chem Soc; 2014 Jan; 136(1):116-8. PubMed ID: 24364388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
